N-(4-bromobenzyl)-3,4-dimethoxyaniline | 1019564-74-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(4-bromobenzyl)-3,4-dimethoxyaniline
• 英文别名: N-[(4-bromophenyl)methyl]-3,4-dimethoxyaniline
• CAS: 1019564-74-9
• 化学式: C₁₅H₁₆BrNO₂
• 分子量: 322.202
• InChiKey: HQPPKZKEIJTBPV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  19
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  30.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N-(4-bromobenzyl)-3,4-dimethoxyaniline 在 tris(dibenzylideneacetone)dipalladium (0) 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 三乙胺 、 N,N-二异丙基乙胺 、 三(邻甲基苯基)磷 、 三氟乙酸 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 生成 (E)-N-(2-aminophenyl)-3-(4-((3,4-dimethoxyphenylamino)methyl)phenyl)acrylamide
  参考文献：
  名称：

  Substituted N-(2-aminophenyl)-benzamides, (E)-N-(2-aminophenyl)-acrylamides and their analogues: Novel classes of histone deacetylase inhibitors

  摘要：

  Inhibition of historic deacetylases (HDACs) is emerging as a new strategy in human cancer therapy. Novel 2-aminophenyl benzamides and acrylamides, that can inhibit human HDAC enzymes and induce hyperacetylation of histories in human cancer cells, have been designed and synthesized. These compounds selectively inhibit proliferation and cause cell cycle arrest in various human cancer cells but not in normal cells. The growth inhibition of 2-aminophenyl benzamides and acrylamides against human cancer cells in vitro is reversible and is dependent on the induction of historic acetylation. Compounds of this class can significantly reduce tumor growth in human tumor xenograft models. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.05.005
• 作为产物：
  描述：

  N-[(4-bromophenyl)methylene]-3,4-dimethoxybenzenamine 在 sodium tetrahydroborate 作用下， 以 甲醇 为溶剂， 生成 N-(4-bromobenzyl)-3,4-dimethoxyaniline
  参考文献：
  名称：

  环丙烷甲醛和N-苄基苯胺的无金属开环环化：对功能化苯并[b]氮杂衍生物的生态友好利用

  摘要：

  在此，我们报道了对丙烷磺酸和环丙烷苯甲醛与N-苄基苯胺的对甲苯磺酸（PTSA）引发的温和且用户友好的开环/多米诺环开环反应（取决于N-苄基苯胺中存在的取代基） 4-氨基丁醛/ 2,3-二氢-1 H-苯并[ b ]氮杂。产物二氢-1 H-苯并[ b ]氮杂也被转化为相应的四氢-1 H-苯并[ b ]氮杂。

  DOI：

  10.1002/adsc.201801714

文献信息

• Metal‐Free Ring Opening Cyclization of Cyclopropane Carbaldehydes and <i>N</i> ‐Benzyl Anilines: An Eco‐Friendly Access to Functionalized Benzo[ <i>b</i> ]azepine Derivatives
  作者：Raghunath Dey、Prabal Banerjee

  DOI：10.1002/adsc.201801714

  日期：2019.6.18

  Herein, we report a p‐toluenesulfonic acid (PTSA) initiated mild and user‐friendly ring opening/domino ring opening cyclization reaction (depends on substituent present in N‐benzyl aniline) of cyclopropane carbaldehyde and N‐benzyl aniline towards the formation of substituted 4‐amino butanal/2,3‐dihydro‐1H‐benzo[b]azepine. The product dihydro‐1H‐benzo[b]azepine was also converted into the corresponding

  在此，我们报道了对丙烷磺酸和环丙烷苯甲醛与N-苄基苯胺的对甲苯磺酸（PTSA）引发的温和且用户友好的开环/多米诺环开环反应（取决于N-苄基苯胺中存在的取代基） 4-氨基丁醛/ 2,3-二氢-1 H-苯并[ b ]氮杂。产物二氢-1 H-苯并[ b ]氮杂也被转化为相应的四氢-1 H-苯并[ b ]氮杂。
• Substituted N-(2-aminophenyl)-benzamides, (E)-N-(2-aminophenyl)-acrylamides and their analogues: Novel classes of histone deacetylase inhibitors
  作者：Oscar Moradei、Silvana Leit、Nancy Zhou、Sylvie Fréchette、Isabelle Paquin、Stéphane Raeppel、Frédéric Gaudette、Giliane Bouchain、Soon H. Woo、Arkadii Vaisburg、Marielle Fournel、Ann Kalita、Aihua Lu、Marie-Claude Trachy-Bourget、Pu T. Yan、Jianhong Liu、Zuomei Li、Jubrail Rahil、A. Robert MacLeod、Jeffrey M. Besterman、Daniel Delorme

  DOI：10.1016/j.bmcl.2006.05.005

  日期：2006.8

  Inhibition of historic deacetylases (HDACs) is emerging as a new strategy in human cancer therapy. Novel 2-aminophenyl benzamides and acrylamides, that can inhibit human HDAC enzymes and induce hyperacetylation of histories in human cancer cells, have been designed and synthesized. These compounds selectively inhibit proliferation and cause cell cycle arrest in various human cancer cells but not in normal cells. The growth inhibition of 2-aminophenyl benzamides and acrylamides against human cancer cells in vitro is reversible and is dependent on the induction of historic acetylation. Compounds of this class can significantly reduce tumor growth in human tumor xenograft models. (c) 2006 Elsevier Ltd. All rights reserved.